ECSP11010752A - Composiciones farmacéuticas basadas en antagonistas del receptor de quinina b2 y corticosteroides - Google Patents

Composiciones farmacéuticas basadas en antagonistas del receptor de quinina b2 y corticosteroides

Info

Publication number
ECSP11010752A
ECSP11010752A EC2011010752A ECSP11010752A ECSP11010752A EC SP11010752 A ECSP11010752 A EC SP11010752A EC 2011010752 A EC2011010752 A EC 2011010752A EC SP11010752 A ECSP11010752 A EC SP11010752A EC SP11010752 A ECSP11010752 A EC SP11010752A
Authority
EC
Ecuador
Prior art keywords
pharmaceutical compositions
quinina
corticosteroids
antagonists
receiver
Prior art date
Application number
EC2011010752A
Other languages
English (en)
Inventor
Sandro Giuliani
Carlo Alberto Maggi
Original Assignee
Luso Farmaco Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luso Farmaco Inst filed Critical Luso Farmaco Inst
Publication of ECSP11010752A publication Critical patent/ECSP11010752A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Composiciones farmacéuticas que contienen, como ingredientes activos, una mezcla de un corticosteroide y un antagonista del receptor de quinina B2. Se ha comprobado que dichas composiciones son particularmente eficaces, en especial en el tratamiento de trastornos inflamatorios, tales como el asma, de trastornos oftálmicos o dérmicos, y sobre todo, de trastornos relacionados con las articulaciones y con la artritis.
EC2011010752A 2008-07-11 2011-01-10 Composiciones farmacéuticas basadas en antagonistas del receptor de quinina b2 y corticosteroides ECSP11010752A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2008A001264A IT1391236B1 (it) 2008-07-11 2008-07-11 Composizioni farmaceutiche a base di antagonisti del recettore b2 delle chinine e corticosteroidi e loro uso
PCT/EP2009/004847 WO2010003601A1 (en) 2008-07-11 2009-07-03 Pharmaceutical compositions based on kinin b2 receptor antagonists and corticosteroids, and their use

Publications (1)

Publication Number Publication Date
ECSP11010752A true ECSP11010752A (es) 2011-04-29

Family

ID=40466843

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2011010752A ECSP11010752A (es) 2008-07-11 2011-01-10 Composiciones farmacéuticas basadas en antagonistas del receptor de quinina b2 y corticosteroides

Country Status (35)

Country Link
US (1) US8476276B2 (es)
EP (1) EP2303268B1 (es)
JP (1) JP5791501B2 (es)
KR (1) KR101656324B1 (es)
CN (1) CN102088975B (es)
AP (1) AP2803A (es)
AR (1) AR072734A1 (es)
AU (1) AU2009267416B2 (es)
BR (1) BRPI0915866A2 (es)
CA (1) CA2730420A1 (es)
CO (1) CO6341556A2 (es)
CR (1) CR20110021A (es)
CY (1) CY1112900T1 (es)
DK (1) DK2303268T3 (es)
EA (1) EA019903B1 (es)
EC (1) ECSP11010752A (es)
ES (1) ES2389872T3 (es)
GE (1) GEP20135792B (es)
HN (1) HN2011000089A (es)
HR (1) HRP20120678T1 (es)
IL (1) IL210554A0 (es)
IT (1) IT1391236B1 (es)
MA (1) MA32542B1 (es)
MX (1) MX2011000350A (es)
MY (1) MY150477A (es)
NI (1) NI201100014A (es)
NZ (1) NZ590427A (es)
PL (1) PL2303268T3 (es)
PT (1) PT2303268E (es)
RS (1) RS52418B (es)
SI (1) SI2303268T1 (es)
TW (1) TWI499419B (es)
UA (1) UA100060C2 (es)
WO (1) WO2010003601A1 (es)
ZA (1) ZA201100287B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120190653A1 (en) * 2011-01-20 2012-07-26 Dow Pharmaceutical Sciences, Inc. Therapeutic eye drop comprising doxycycline and a stabilizer
JP2016514141A (ja) * 2013-03-14 2016-05-19 シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド Ｂ２−ブラジキニン受容体媒介の血管浮腫の治療方法
CN104072585A (zh) * 2014-07-21 2014-10-01 成都圣诺生物科技股份有限公司 一种合成艾替班特的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2451602A1 (en) * 2001-06-26 2003-01-03 Metaphore Pharmaceuticals, Inc. Combination therapy of an sodm and a corticosteroid for prevention and/or treatment of inflammatory disease
ITMI20021247A1 (it) * 2002-06-07 2003-12-09 Menarini Ricerche Spa Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche
DE10304994A1 (de) * 2003-02-07 2004-09-02 Aventis Pharma Deutschland Gmbh Die Verwendung von Antagonisten des Bradykinin-B2 Rezeptors zur Behandlung von Osteoarthrose
ITMI20041963A1 (it) * 2004-10-15 2005-01-15 Luso Farmaco Inst "antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche"
EP1741444A1 (en) * 2005-07-05 2007-01-10 Jerini AG Kinin antagonists for treating bladder dysfunction
EP1894559A1 (en) * 2006-09-01 2008-03-05 PARI Pharma GmbH Means to solubilise steroids for inhalation

Also Published As

Publication number Publication date
KR20110044970A (ko) 2011-05-03
HRP20120678T1 (hr) 2012-09-30
CN102088975A (zh) 2011-06-08
UA100060C2 (uk) 2012-11-12
PT2303268E (pt) 2012-09-24
MX2011000350A (es) 2011-02-22
GEP20135792B (en) 2013-03-25
EP2303268B1 (en) 2012-06-20
KR101656324B1 (ko) 2016-09-09
WO2010003601A1 (en) 2010-01-14
MY150477A (en) 2014-01-30
CR20110021A (es) 2011-07-11
HK1158547A1 (en) 2012-07-20
MA32542B1 (fr) 2011-08-01
JP2011527296A (ja) 2011-10-27
CN102088975B (zh) 2013-08-21
RS52418B (sr) 2013-02-28
PL2303268T3 (pl) 2012-11-30
EA201100013A1 (ru) 2011-08-30
NI201100014A (es) 2011-09-13
CA2730420A1 (en) 2010-01-14
HN2011000089A (es) 2013-01-28
CY1112900T1 (el) 2016-04-13
NZ590427A (en) 2012-09-28
TWI499419B (zh) 2015-09-11
ES2389872T3 (es) 2012-11-02
AP2011005572A0 (en) 2011-02-28
TW201006471A (en) 2010-02-16
EA019903B1 (ru) 2014-07-30
ITMI20081264A1 (it) 2010-01-12
AU2009267416A1 (en) 2010-01-14
AP2803A (en) 2013-11-30
AR072734A1 (es) 2010-09-15
ZA201100287B (en) 2012-03-28
SI2303268T1 (sl) 2012-10-30
WO2010003601A8 (en) 2010-03-18
CO6341556A2 (es) 2011-11-21
US8476276B2 (en) 2013-07-02
BRPI0915866A2 (pt) 2015-11-03
IT1391236B1 (it) 2011-12-01
AU2009267416B2 (en) 2013-09-12
JP5791501B2 (ja) 2015-10-07
US20110112011A1 (en) 2011-05-12
DK2303268T3 (da) 2012-07-23
IL210554A0 (en) 2011-03-31
EP2303268A1 (en) 2011-04-06

Similar Documents

Publication Publication Date Title
UY30917A1 (es) Moduladores 2-aminopiridina del receptor histamina h
MX2013006040A (es) Antagonistas del receptor de acido lisofosfatidico y su uso en el tratamiento de fibrosis.
CL2008001632A1 (es) Compuestos derivados de acidos benzoilamino-indan-2-carboxilicos sustituidos, inhibidores del receptor cxcr5; composicion farmaceutica; y su uso en el tratamiento de efecciones fisiologicas inflamatorias, tales como artritis reumatoidea y asma.
MY163055A (en) Polycyclic antagonists of lysophosphatidic acid receptors
TN2012000126A1 (en) Polycyclic compounds as lysophosphatidic acid receptor antagonists
CL2014001664A1 (es) Compuestos derivados de 2-([1,4]dioxan-2-ilmetoxi)-6,7-dihidropirimido[6,1-a]isoquinolin-4-ona, antagonistas del receptor gpr84; composicion farmaceutica; metodo de tratamiento o profilaxis; y uso en el tratamiento o profilaxis de afecciones inflamatorias tales como artritis reumatoide, vasculitis, asma y psoriasis, entre otras.
CL2016000188A1 (es) Composiciones de arní de serpinc1 y métodos de uso de las mismas
PH12014502789A1 (en) N-alkyltriazole compounds as lpar antagonists
UA110310C2 (uk) Сполуки n-арилтриазолу як антагоністи рецепторів лізофосфатидної кислоти (lpar)
PE20150631A1 (es) Formas cristalinas de un modulador del receptor androgenico
CO6690805A2 (es) 6-amino-nicotinamidas sustituidas como modulares de kcnq2/3
EA201390803A1 (ru) Ингибиторы бромодомена и их применение
CL2011000668A1 (es) Compuestos derivados de pirazolopiridina; proceso de preparacion; composicion farmaceutica y uso en el tratamiento de enfermedades tales como artritis reumatoide, psoriasis, esclerosis multiple, entre otras.
PE20181523A1 (es) Tratamiento de lupus nefritis usando laquinimod
EP4414376A3 (en) Novel depsipeptide and uses thereof
EA201391618A1 (ru) Комбинация, содержащая умеклидиний и кортикостероид
HK1218543A1 (zh) 新型磺酰胺trpa1受体拮抗剂
ECSP13012453A (es) 2-oxi-quinolina-3-carboxamidas sustituidas como moduladores KCNQ2/3
BR112014031706A8 (pt) Composições farmacêuticas orais, e composição farmacêutica oral compreendendo itraconazol
JOP20190156B1 (ar) أميدات عطرية لحمض الكربوكسيليك بصفتها مضادات لمستقبلة البراديكينين b1
ECSP11010752A (es) Composiciones farmacéuticas basadas en antagonistas del receptor de quinina b2 y corticosteroides
CO6270301A2 (es) Composiciones farmaceuticas que contienen antagonistas de bradiquinina y acido hialuronico y sus usos
BR112013024137A2 (pt) composições de antagonistas de opióides e seu uso para o tratamento da esclerodermia
TR200909785A1 (tr) Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.
UY32679A (es) Antagonistas policíclicos de receptores de ácido lisofosfatidico